Treace Medical Concepts
TMCI · NASDAQ
About TMCI
- Employees
- 450
- Headquarters
- Ponte Vedra, Florida
- Listed
- Apr 23, 2021
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- treace.com
TMCI key statistics
- Market cap
- 264.69M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 226.46K
- Volume
- 184.22K
- Open price
- $3.92
- High today
- $4.09
- Low today
- $3.88
- 52 Week high
- $7.08
- 52 Week low
- $1.17
Treace Medical Concepts (TMCI) at a glance
Treace Medical Concepts (TMCI) last traded at $4.07, with a market cap of 264.69M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $3.88 and $4.09. The current price is 5.0% above the day's low and 0.4% below its high.
Volume so far is 184.22K shares, in line with the average of 226.46K shares a day.
Over the past year Treace Medical Concepts has ranged from $1.17 to $7.08, and now sits 49% of the way up that range.
Treace Medical Concepts met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported -$0.24 per share against an estimate of -$0.304.
The average analyst price target is $5.61, 37.8% above the current price, from 6 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy16.7%
- Hold66.7%
- Sell16.7%
- Low
- $4.55
- Now
- $4.07
- High
- $7.35
TMCI earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 18.8% on average.
- Q3 FY24: reported -$0.25 per share against an estimate of -$0.2771
- Q4 FY24: reported -$0.01 per share against an estimate of -$0.0393
- Q1 FY25: reported -$0.25 per share against an estimate of -$0.3075
- Q2 FY25: reported -$0.28 per share against an estimate of -$0.2941
- Q3 FY25: reported -$0.26 per share against an estimate of -$0.2856
- Q4 FY25: reported -$0.15 per share against an estimate of -$0.153
- Q1 FY26: reported -$0.28 per share against an estimate of -$0.3142
- Q2 FY26: reported -$0.24 per share against an estimate of -$0.304
TMCI news
- Press releasePRNewswire
- Press releasePRNewswire
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Avi Kapoor
US Stocks Mixed; Dow Falls Over 100 Points
- Press releaseGlobe Newswire
Johnson Fistel, PLLP Investigates Claims on Behalf of Long‑Term Shareholders of Quantum Computing Inc. (QUBT), Quanex Building Products Corporation (NX), Treace Medical Concepts, Inc. (TMCI), and BigBear.ai Holdings, Inc. (BBAI)
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts
12 Health Care Stocks Moving In Friday's After-Market Session
- Avi Kapoor
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
12 Health Care Stocks Moving In Friday's Intraday Session
Similar companies
Companies in the same industry as Treace Medical Concepts
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.